Bartter syndrome type 2 is a rare genetic kidney condition that affects salt balance and fluid levels. It usually starts in infancy or early childhood and lasts lifelong. Common signs include frequent urination, thirst, muscle cramps, and poor growth, and doctors may find low potassium and metabolic alkalosis. Many people with Bartter syndrome type 2 do well with treatment such as potassium and magnesium supplements, salt as advised, and medicines that reduce salt loss. The outlook varies, but many people live long and full lives with regular kidney care.
Overview
Bartter syndrome type 2Symptoms
In Bartter syndrome type 2, early symptoms can start before birth with excess amniotic fluid and early delivery. Babies and children often have frequent urination, intense thirst, dehydration, poor growth, vomiting, muscle weakness, and sometimes calcium deposits in the kidneys.
Outlook and prognosis
Many living with Bartter syndrome type 2 can grow and learn well with steady care, salt and potassium support, and close monitoring. Kidney function is often stable, though some develop reduced function over time. Regular follow‑up helps prevent dehydration, rhythm problems, and growth delays.
Causes and risk factors
Bartter syndrome type 2 is caused by harmful changes in the KCNJ1 (ROMK) gene, affecting kidney salt handling. It’s inherited in an autosomal recessive way. Risk rises with parental carrier status, family history, or consanguinity; environment influences severity, not cause.
Genetic influences
Genetics are central in Bartter syndrome type 2. It’s caused by inherited changes in the KCNJ1 gene, usually passed in an autosomal recessive pattern. Variants disrupt kidney salt handling, shaping severity, age at diagnosis, and response to treatments.
Diagnosis
Doctors suspect Bartter syndrome type 2 from clinical features and characteristic blood and urine electrolyte patterns. Kidney imaging may show nephrocalcinosis, and genetic diagnosis of Bartter syndrome type 2 is confirmed by KCNJ1 testing.
Treatment and drugs
Treatment for Bartter syndrome type 2 focuses on replacing what the kidneys lose and protecting growth, bones, and the heart. Care often includes potassium and magnesium supplements, sodium as needed, and medicines like NSAIDs or potassium‑sparing diuretics. Regular checks guide doses and support hydration.
Symptoms
Many families first notice changes around feeding, diapers, and growth. Bartter syndrome type 2 often shows up early, affecting how the kidneys handle salt and water. Parents and clinicians often notice early features of Bartter syndrome type 2 in late pregnancy or the first months of life. Features vary from person to person and can change over time.
Too much fluid around the baby and early labor can be first signs. Babies may arrive early and need help with fluids. Clinicians call this polyhydramnios and prematurity, which means extra fluid and earlier birth.
Babies and children pass large amounts of urine. This can mean very wet diapers and more bathroom trips at night. For many families, this is one of the earliest home signs.
Children may want to drink water often and in large amounts. They may wake at night for drinks. Without enough fluids, dehydration can develop quickly.
Dry mouth, fewer tears, or dizziness can appear during illness or heat. For many with Bartter syndrome type 2, low blood pressure adds to lightheadedness. Extra fluids and salts are often needed when sick.
How people usually first notice Bartter syndrome type 2?
Parents and doctors often first notice Bartter syndrome type 2 in the newborn period because babies have trouble feeding, aren’t gaining weight as expected, and pee far more than usual, leading to dehydration even with frequent feeds. Blood tests done for poor feeding or jaundice may reveal low potassium and chloride with metabolic alkalosis, and urine tests show high salt loss, which points toward a salt-wasting kidney problem. In some cases it’s picked up prenatally when routine ultrasounds show too much amniotic fluid (polyhydramnios), leading to early delivery and immediate checks for the first signs of Bartter syndrome type 2 after birth.
Types of Bartter syndrome type 2
Bartter syndrome type 2 is a rare inherited kidney condition, and there are no widely accepted clinical variants within type 2 itself. In medical terms, type 2 refers specifically to changes in the KCNJ1 gene (which encodes the ROMK channel), and that single genetic cause defines the subtype. People with Bartter syndrome type 2 can still vary in how early symptoms start and how severe they are, but these are differences within the same subtype rather than distinct types. Not everyone will experience every type of symptom pattern, and the balance of symptoms can shift over time.
No distinct variants
In current clinical genetics, Bartter syndrome type 2 is considered a single, defined subtype based on KCNJ1/ROMK changes. Differences in age at onset, severity, or complications reflect individual variability rather than recognized variants.
Age at presentation
Some infants show symptoms in the newborn period, while others are diagnosed later in infancy or early childhood. This range reflects how strongly the same gene change affects kidney salt handling.
Severity spectrum
For many, signs like salt wasting, dehydration risk, and low potassium vary from mild to more pronounced. Even within Bartter syndrome type 2, intensity can range from mild to severe.
Prenatal features
Certain pregnancies show extra amniotic fluid and early growth concerns, while others do not. These prenatal differences do not represent separate types of Bartter syndrome type 2.
Types wording note
When people search for types of Bartter syndrome type 2, they’re usually comparing type 2 with other Bartter subtypes (types 1, 3, 4, 5). Within type 2, however, no distinct clinical variants are widely recognized.
What genetics can tell you about symptoms
Some people with Bartter syndrome type 2 have mutations in the KCNJ1 gene, which disrupt a kidney potassium channel and lead to salt wasting, frequent urination, dehydration, muscle cramps, and sometimes low blood pressure. Newborns may have polyhydramnios, prematurity, and life‑threatening electrolyte imbalances.
Causes and risk factors
Bartter syndrome type 2 is caused by changes in the KCNJ1 gene that disrupt a kidney salt channel.
It is inherited in an autosomal recessive way, so a child is affected when both parents are carriers.
Most cases are inherited, but rare cases happen as a new gene change with no family history.
Risk factors for Bartter syndrome type 2 include having carrier parents or an affected sibling, and the chance is higher when parents are closely related.
Genes set the stage, but environment and lifestyle often decide how the story unfolds, and illness, dehydration, or heat can worsen symptoms even though they do not cause the condition.
Environmental and biological risk factors
Understanding what can raise the chance of Bartter syndrome type 2 can help you focus your energy where it counts. This rare kidney condition is present from birth, and current research has not identified outside exposures that cause it. Some risks are carried inside the body, others come from the world around us. For this condition, the evidence points to internal drivers, with no proven environmental factor increasing the likelihood that it occurs.
To date, no specific pregnancy exposure has been shown to cause Bartter syndrome type 2. Medicines, infections, and common environmental toxins have not been linked to a higher chance. General prenatal health remains important for overall fetal development.
There is no clear evidence that advanced maternal or paternal age increases the likelihood of Bartter syndrome type 2. Cases are reported across many age groups of parents.
Being born early does not create Bartter syndrome type 2. When prematurity occurs, it is usually related to conditions during the pregnancy rather than a cause of the syndrome.
Living with air pollution, heavy metals, or pesticides has not been shown to raise the chance of Bartter syndrome type 2. No consistent association has been found between these exposures and occurrence.
Genetic risk factors
Changes in a single kidney gene are the root cause of Bartter syndrome type 2. Some risk factors are inherited through our genes. In most families, the condition appears when a child receives two nonworking copies—one from each parent who are healthy carriers. Here’s what is known about the genetic causes and genetic risk factors for Bartter syndrome type 2.
KCNJ1 gene changes: Variants in the KCNJ1 gene, which makes a kidney potassium channel called ROMK, directly cause Bartter syndrome type 2. These changes reduce or block the channel’s function and disturb salt and potassium balance.
Autosomal recessive: The condition develops when both copies of KCNJ1 are nonworking. People with only one changed copy are carriers and typically have no symptoms.
Carrier couple risk: When both parents carry a KCNJ1 change, each pregnancy has a 25% (1 in 4) chance of Bartter syndrome type 2. There is also a 50% chance for a healthy carrier and a 25% chance for a child with no changes.
Family history: Having an affected sibling suggests both parents are carriers of a KCNJ1 change. This makes the chance higher that future children could also be affected. Genetic counseling can help families understand specific numbers.
Parental relatedness: Parents who are blood relatives are more likely to share the same KCNJ1 change. This increases the likelihood of a child inheriting Bartter syndrome type 2.
Founder variants: In some communities, certain shared KCNJ1 changes are more frequent because of a common ancestor in the past. People from these backgrounds may have higher carrier rates and a greater chance that two carriers have a child together.
Variant effects: Some gene changes stop KCNJ1 from working completely, while others leave partial function. This can influence how early and how strongly features appear. Exact prediction from a specific change is not always possible.
Lifestyle risk factors
Lifestyle habits do not cause Bartter syndrome type 2, but daily choices can influence electrolyte balance, symptoms, and complications. Understanding how lifestyle affects Bartter syndrome type 2 helps you reduce avoidable potassium and fluid losses. The items below focus on lifestyle risk factors for Bartter syndrome type 2 that can worsen salt-wasting and dehydration. Always align these choices with your clinician’s individualized plan.
Inadequate fluid intake can worsen dizziness, kidney stress, and electrolyte imbalances in Bartter syndrome type 2. Planned, frequent drinking helps match ongoing urine and sweat losses and supports blood pressure stability.
Low-salt diets can aggravate salt-wasting, lowering blood pressure and increasing symptoms. Guided liberal salt intake, as advised by your clinician, can support volume status and reduce secondary hormone surges.
Skimping on potassium-rich foods may deepen hypokalemia and muscle weakness. Emphasizing potassium-containing choices within your care plan can help buffer losses between supplement doses.
Poor magnesium intake can make low potassium harder to correct. Including magnesium-rich foods or approved supplements may reduce cramps and help stabilize potassium levels.
Risk prevention
Bartter syndrome type 2 is a genetic kidney condition, so you can’t prevent the condition itself. Prevention focuses on avoiding dehydration, keeping salts balanced, and protecting the kidneys to reduce complications over time. Prevention can mean both medical steps, like prescribed treatments and monitoring, and lifestyle steps, like steady hydration. Knowing early symptoms of Bartter syndrome type 2 can help families seek care sooner.
A genetics professional can explain inheritance, carrier testing, and reproductive options. This can include prenatal testing or embryo testing to lower the chance of having an affected child.
Spotting signs in infancy—such as frequent urination, thirst, or poor weight gain—can speed referral to a kidney specialist. Earlier care helps prevent dehydration and salt imbalance.
Keep fluids available throughout the day, with extra during fever, heat, or activity. Your care team can tailor fluid goals for age, weight, and weather.
Prescribed salt (sodium and sometimes magnesium) helps offset kidney salt loss. Take exactly as directed to avoid swings in blood pressure or electrolytes.
Transmission
Bartter syndrome type 2 is not contagious; it cannot be caught from someone else or spread through everyday contact. It is inherited, most often in an autosomal recessive pattern, meaning both parents usually carry one changed copy of a kidney salt‑handling gene but do not have symptoms. When both parents are carriers, each pregnancy has a 25% chance of a child having Bartter syndrome type 2, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither changed copy. New, spontaneous changes affecting both gene copies are possible but very rare; most cases reflect the genetic transmission of Bartter syndrome type 2 from carrier parents.
When to test your genes
Consider genetic testing if you had unexplained salt loss, low potassium, or dehydration in infancy, or if a close relative has Bartter syndrome type 2. Testing helps confirm the diagnosis, guide electrolyte and kidney care, and inform family planning. Pregnant individuals or couples with a family history may consider carrier testing and prenatal options.
Diagnosis
Bartter syndrome type 2 is usually recognized in infancy based on a pattern of salt loss, dehydration, and specific lab findings, then confirmed with genetic testing. Doctors look at the whole picture—pregnancy history, newborn course, growth, blood and urine tests, and kidney imaging—to piece things together. Getting a diagnosis is often a turning point toward answers and support. The genetic diagnosis of Bartter syndrome type 2 typically combines these clinical clues with a DNA test that identifies changes in a gene called KCNJ1 (also known as ROMK).
Providers look for frequent urination, poor weight gain, and signs of dehydration in babies or young children. Blood pressure is often normal or on the low side. These features raise suspicion for a salt-wasting kidney condition.
Many pregnancies have high amniotic fluid (polyhydramnios) and may end in early delivery. This happens because the fetus passes large amounts of urine. These clues support an antenatal form of Bartter syndrome type 2.
Doctors usually begin with blood tests that check salts like potassium and chloride. Low potassium with metabolic alkalosis is common in Bartter syndrome type 2. Sodium may also run low during dehydration.
A blood gas or similar test looks for metabolic alkalosis, which fits with ongoing salt loss. This helps separate Bartter syndrome type 2 from conditions that cause acidosis. Results are interpreted alongside electrolytes and symptoms.
Stages of Bartter syndrome type 2
Bartter syndrome type 2 does not have defined progression stages. Symptoms and test results can shift with age and hydration, so it’s described by its pattern of salt loss and how it’s managed over time rather than a step-by-step decline; early symptoms of Bartter syndrome type 2 may be noticed before birth or soon after delivery. Different tests may be suggested to help confirm the diagnosis and rule out similar conditions, including blood and urine salt levels, acid–base balance, and sometimes genetic testing. Ongoing care usually involves regular checks of electrolytes, growth, and kidney function so any changes can be addressed promptly.
Outlook and prognosis
Looking at the long-term picture can be helpful. Many people with Bartter syndrome type 2 grow into adulthood, go to school or work, and build active lives, though they may need ongoing care for salt balance and kidney function. Early care can make a real difference, especially in preventing dehydration in infancy, supporting growth, and protecting the kidneys over time.
Prognosis refers to how a condition tends to change or stabilize over time. In Bartter syndrome type 2, the early symptoms of Bartter syndrome type 2 often start in the first months of life with vomiting, poor weight gain, muscle cramps, or episodes of dehydration. With consistent treatment—salt and fluids, magnesium and potassium supplements, and sometimes medicines that reduce salt loss—many living with Bartter syndrome type 2 maintain steady health between flare-ups. Kidney health is the key long-term concern; a subset develop chronic kidney disease in adolescence or adulthood, so regular monitoring of blood pressure, electrolytes, and kidney filtration is important.
Everyone’s journey looks a little different. Some people have frequent hospital visits in early childhood but fewer issues later, while others need ongoing adjustments to medicines and supplements throughout life. Life expectancy is usually near normal when dehydration and electrolyte shifts are treated promptly, but severe, untreated imbalances can be dangerous, particularly in infants. Talk with your doctor about what your personal outlook might look like, including how your lab results, growth, and kidney trends shape your individual prognosis.
Long-term effects
Bartter syndrome type 2 often has lifelong effects that start early and change with age. Early features of Bartter syndrome type 2 can include heavy urination, intense thirst, and slow weight gain in infancy, with some aspects easing as children grow. Long-term effects vary widely, and some people see a steadier course over time. Kidney changes and electrolyte shifts are the main drivers of the outlook.
The kidneys keep losing salt, leading to frequent urination and strong thirst. This pattern often continues from infancy into adulthood, though the intensity can lessen.
Lifelong dips in blood potassium can cause muscle cramps, weakness, or fatigue. This can also raise the risk of irregular heart rhythms.
Babies and children may have slow weight gain and height compared with peers. Some catch-up occurs, but a shorter adult height is possible, and puberty can be delayed.
Calcium can build up in the kidneys (nephrocalcinosis) or form stones. These changes can cause pain or infections and may slowly affect kidney function. Doctors may track these changes over years to see how the kidneys are doing.
How is it to live with Bartter syndrome type 2?
Living with Bartter syndrome type 2 often means planning your day around fluids, salt, and bathroom breaks, because the kidneys lose salt and water faster than the body can hold onto them. For many, this can bring muscle cramps, fatigue, and episodes of weakness, especially during heat, exercise, or illness, and in babies it can show up as poor weight gain and frequent wet diapers. School, work, and travel usually remain possible with preparation—access to water and electrolyte-rich drinks, regular lab checks, and medications that help balance minerals. Family members, caregivers, and teachers often play a key role by helping with routines, watching for dehydration or low potassium symptoms, and supporting medical visits, which eases the load and helps daily life run more smoothly.
Treatment and drugs
Treatment for Bartter syndrome type 2 focuses on easing salt loss, protecting the kidneys, and supporting growth and everyday energy. Doctors often recommend high-salt intake (with careful monitoring), potassium and magnesium supplements, and medicines that reduce salt wasting in the kidneys, such as nonsteroidal anti-inflammatory drugs like indomethacin or ibuprofen, and sometimes potassium-sparing diuretics. In babies and children, nutrition support and close tracking of fluids help prevent dehydration and support normal growth; some may need IV fluids during illnesses. Your doctor may adjust your dose to balance benefits and side effects, especially with NSAIDs, which can irritate the stomach and affect kidney function. Regular follow-up with a kidney specialist helps tailor care over time and check for complications like low potassium, metabolic alkalosis, or changes in kidney function.
Non-drug treatment
Living with Bartter syndrome type 2 often means managing salt and fluid balance day to day. Alongside medicines, non-drug therapies can make symptoms easier to handle and help protect the kidneys over time. Catching early symptoms of Bartter syndrome type 2—like frequent urination, thirst, and poor weight gain—can guide these steps sooner. Plans are tailored by age, growth needs, and how active salt-wasting is.
Extra salt helps replace what the kidneys waste and supports blood pressure and growth. A dietitian can guide safe amounts and ways to fortify foods or formula.
Foods like bananas, potatoes, beans, and leafy greens can support potassium levels. Meal plans focus on steady intake across the day.
Balanced electrolyte drinks can help during hot weather, exercise, fevers, or stomach bugs. They replace salt and fluids lost faster than water alone.
Regular fluids spaced through the day can prevent dips in energy and reduce headaches from dehydration. Schools or workplaces may need a plan for water and bathroom access.
Your genes may have an impact on how drugs work for you
Your genes can change how your body moves, breaks down, or responds to medicines used for Bartter syndrome type 2, including potassium supplements and drugs that reduce kidney salt loss. Variants in ROMK and drug‑handling genes may shift dosing needs and side‑effect risks.
Pharmacological treatments
Treatment for Bartter syndrome type 2 focuses on replacing lost salts, easing excessive urine output, protecting the kidneys, and supporting growth. Early symptoms of Bartter syndrome type 2 often appear in infancy, so medicines are usually started young and adjusted over time. Not everyone responds to the same medication in the same way. Plans are tailored based on labs, growth, blood pressure, and how someone feels day to day.
Oral potassium chloride helps correct low potassium and muscle weakness. Doses are split through the day to keep levels steady and reduce stomach upset. Levels are checked often to avoid both too low and too high potassium.
Salt tablets or solution replace sodium losses that drive thirst, dehydration, and dizziness. This can improve energy and help maintain normal blood pressure. Intake is adjusted with season, illness, and lab results.
Magnesium oxide or magnesium glycinate is used if blood magnesium is low. Replacing magnesium can make potassium replacement work better. Diarrhea can occur, so dosing is adjusted to tolerance.
Indomethacin or ibuprofen lowers prostaglandins, reducing urine volume and salt loss. Celecoxib may be used if stomach side effects are a concern. Kidney function, blood pressure, and stomach symptoms are monitored closely.
Genetic influences
In Bartter syndrome type 2, changes in a single gene that helps kidney cells move potassium and salt are usually the cause. It follows an autosomal recessive pattern: a child must inherit two nonworking copies—one from each parent—to develop the condition, while parents are typically healthy carriers. A “carrier” means you hold the gene change but may not show symptoms. When both parents carry the change, each pregnancy has a 25% chance of having a child with Bartter syndrome type 2, a 50% chance of a carrier child, and a 25% chance of a child with no change. Severity can vary even within the same family, and some children see symptoms ease as they grow. Understanding the inheritance pattern of Bartter syndrome type 2 can guide family planning and support timely diagnosis. Genetic testing can confirm a change in the KCNJ1 (ROMK) gene and help identify at-risk relatives or options such as prenatal or preimplantation testing.
Is Bartter syndrome type 2 genetic?
Genetics are central in Bartter syndrome type 2. It’s caused by inherited changes in the KCNJ1 gene, usually passed in an autosomal recessive pattern. Variants disrupt kidney salt handling, shaping severity, age at diagnosis, and response to treatments.
Pharmacogenetics—how genetics influence drug effects
Your specific gene change in Bartter syndrome type 2 directly guides care, because it shapes how your kidneys handle salt and potassium and how you respond to certain medicines. Once the subtype is confirmed by genetic testing, doctors often avoid drugs that increase salt loss (such as loop water pills) and may use potassium‑sparing options, together with ample salt and potassium supplements. When choosing medications used to treat Bartter syndrome type 2, anti‑inflammatory drugs that lower kidney prostaglandins—such as indomethacin or a COX‑2 option like celecoxib—can reduce urine losses and support growth, but they need careful dosing and monitoring for stomach and kidney side effects. Genetic testing can sometimes identify how your body processes certain pain relievers (for example celecoxib or ibuprofen), which can inform dose and side‑effect risks. This type of pharmacogenetic insight doesn’t replace the core treatment goals of replacing salt and potassium, but it can help fine‑tune the NSAID choice and dose for safety. Always review new prescriptions with your care team, as some common medicines—including additional “water pills”—can worsen salt loss in Bartter syndrome type 2, so plans are personalized and adjusted over time.
Interactions with other conditions
Day-to-day, stomach bugs with vomiting or diarrhea, heavy sweating during a heat wave, or fasting before a procedure can drain salt and water and make symptoms of Bartter syndrome type 2 flare, leading to cramps, dizziness, or dehydration. People with Bartter syndrome type 2 are especially sensitive to medicines that lower potassium or increase urine losses—this includes some asthma inhalers (beta-agonists), certain water pills, and stimulant or high-dose laxatives—and very low potassium can raise the risk of irregular heart rhythms. Heart medicines like digoxin are also riskier when potassium runs low, and combining multiple drugs that affect electrolytes can compound the problem. Kidney-related issues such as nephrocalcinosis can overlap with urinary infections or kidney stones; when these occur, they may worsen kidney function and disturb electrolytes further. Ask if any medications for one condition might interfere with treatment for another. During intercurrent illnesses, surgery, or pregnancy, close monitoring of fluids and electrolytes helps prevent sudden swings and keeps Bartter syndrome type 2 as stable as possible.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described newborns who struggled to gain weight, peed unusually often, and craved salt, long before anyone knew why. Families sometimes noticed a pattern—one baby after another with dehydration spells despite careful feeding, hospital stays for high blood levels of certain salts, and parents carrying measuring jugs everywhere to track diapers. Only later did doctors connect these threads to a specific kidney salt‑handling problem now known as Bartter syndrome type 2.
First described in the medical literature as part of a broader “Bartter” group in the 1960s, it took decades to sort out the distinct types. Early reports focused on features doctors could see: low potassium, normal blood pressure despite salt loss, and overactive hormone signals trying to balance fluids. Some infants were very ill; others had milder, later‑recognized forms. Over time, descriptions became more precise, and a pattern emerged—this form often began in the newborn period and could be severe if not treated quickly.
Advances in genetics in the late 1990s and early 2000s changed the story. Researchers found that Bartter syndrome type 2 is linked to changes in a gene that helps kidney cells move potassium. That discovery explained why symptoms start so early and why potassium levels tend to be especially low. It also showed why two parents without symptoms could have more than one child affected: the condition follows an autosomal recessive pattern, meaning a child needs two nonworking copies of the gene to develop the syndrome.
Once considered rare, now recognized as part of a spectrum of inherited salt‑wasting kidney conditions, Bartter syndrome type 2 benefits from newborn and early‑childhood awareness. With each decade, treatments have been refined: careful replacement of fluids and salts, medicines that reduce kidney salt loss, and close monitoring to support growth and protect the kidneys. The earlier the condition is identified, the easier it is to prevent cycles of dehydration and hospital visits.
In recent decades, knowledge has built on a long tradition of observation. Today, when a baby has early symptoms of Bartter syndrome type 2—frequent urination, feeding difficulties, muscle weakness from low potassium—clinicians can confirm the diagnosis with targeted blood and urine tests and, when available, genetic testing. Historical differences highlight why some older case descriptions seem inconsistent: the name “Bartter” once covered several conditions that we now know are genetically and clinically distinct. That clearer picture has improved counseling for families, connected communities with shared experience, and guided research toward therapies tailored to the exact type.